Rankings
▼
Calendar
LGVN Q2 2022 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$18M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$466,000
-4.7% YoY
Gross Profit
$160,000
34.3% margin
Operating Income
-$4M
-905.8% margin
Net Income
-$6M
-1206.9% margin
EPS (Diluted)
$-2.70
QoQ Revenue Growth
+25.9%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$900,000
Balance Sheet
Total Assets
$35M
Total Liabilities
$6M
Stockholders' Equity
$29M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$466,000
$489,000
-4.7%
Gross Profit
$160,000
$208,000
-23.1%
Operating Income
-$4M
-$5M
+16.6%
Net Income
-$6M
-$5M
-12.3%
← FY 2022
All Quarters
Q3 2022 →